PATENT CLAIM ANALYSIS

Application Number: 15957757
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-12
Patent Classification: ["424", "139100"]

Abstract:
The present invention generally relates to antibodies, antigen-binding fragments thereof, polypeptides, and immunoconjugates that bind to CD123 antigen (the a chain of the interleukine 3 receptor, or IL-3Rα). The present invention also relates to methods of using such CD123-binding molecules for diagnosing and treating diseases, such as B-cell malignancies.

Claim (Index 143):
The method of  claim 141 , wherein said cancer is B-cell acute lymphoblastic leukemia (B-ALL).

Metadata:
- Claim Count in Document: 39.0
- Percentile: 91.0
- Lexical Diversity: 1.34884
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15195401', '14217599', '15093777', '14376364', '15563924']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6987041117448859
- 35 USC 102 Novelty (BERT): 0.571879290422201
- Combined Prediction Score: 0.6860216296126175
- Mean Citation Score: 285.4889
- Max Citation Score: 487.65323
- Similarity Product: 326.1140515199614

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test